✨ Medicines and Education Notices




NEW ZEALAND GAZETTE, No. 76 β€” 16 JULY 2015

Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Maxiclear PE 2.5 Sinus and Pain Relief (Pharmacy Only)
Paracetamol 500mg
Phenylephrine hydrochloride 2.5mg
Film coated tablet
AFT Pharmaceuticals Limited
Sigma Laboratories Limited, Goa, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Signifor
Pasireotide diaspartate 0.3762mg/mL equivalent to Pasireotide 0.3mg/mL
Solution for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Signifor
Pasireotide diaspartate 0.7524mg/mL equivalent to Pasireotide 0.6mg/mL
Solution for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Signifor
Pasireotide diaspartate 1.1286mg/mL equivalent to Pasireotide 0.9mg/mL
Solution for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland

Dated this 9th day of July 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go4171

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Glycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Injection
Glycopyrronium bromide 0.5mg/mL
Neostigmine metilsulfate 2.5mg/mL
Solution for injection
Max Health Limited
Martindale Pharmaceuticals, Essex, United Kingdom

Note: This renewed consent is valid for two years from 18 July 2015.

Dated this 9th day of July 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go4172

Notice of Direction to Appoint a Limited Statutory Manager for the Oromahoe (1065) School Board of Trustees

Under section 78M of the Education Act 1989, with delegated authority from the Minister of Education, I hereby direct the appointment of a limited statutory manager for the Oromahoe School (1065) Board of Trustees.

The following functions, powers and duties of the board are to be vested in a limited statutory manager:

  • All functions, powers and duties of the board as an employer (whether statutory or otherwise); and
  • All functions, powers and duties of the board in curriculum management including teaching and assessment

43



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 76





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
9 July 2015
Medicines, Distribution, Consent, Pharmaceuticals, Maxiclear PE 2.5 Sinus and Pain Relief, Signifor
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a Medicine

πŸ₯ Health & Social Welfare
9 July 2015
Medicines, Provisional Consent, Renewal, Glycopyrronium Bromide, Neostigmine Metilsulfate
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸŽ“ Notice of Direction to Appoint a Limited Statutory Manager for the Oromahoe (1065) School Board of Trustees

πŸŽ“ Education, Culture & Science
Education, Statutory Manager, School Board, Oromahoe School, Curriculum Management